Changes in pulmonary function in patients with ulcerative colitis Source: Eur Respir J 2005; 26: Suppl. 49, 375s Year: 2005
Respiratory manifestations in ulcerative colitis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=168 Year: 2005
Prevalence of respiratory disorders in patients with ulcerative colitis Source: Eur Respir J 2007; 30: Suppl. 51, 567s Year: 2007
Pulmonary manifestations in Crohn's disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=151 Year: 2005
Cell profile and lymphocyte subsets from induced sputum (IS) in non atopic patients with ulcerative colitis (UC) Source: Eur Respir J 2004; 24: Suppl. 48, 469s Year: 2004
Expression of heat shock proteins in chronic obstructive pulmonary disease, vernal keratoconjunctivitis and ulcerative colitis Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013
Microcarcinoids of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 94s Year: 2006
Cyclophosphamide in steroid-refractory hypersensitivity pneumonitis and non-classifiable interstitial lung disease Source: International Congress 2017 – Novel and old entities Year: 2017
Bronchiectasis associated with inflammatory bowel disease Source: Eur Respir Mon 2011; 52: 163-177 Year: 2011
Role of bronchial and alveolar exhaled nitric oxide in patients with ulcerative colitis (UC) Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders Year: 2010
Bronchial hyperreactivity in patients with inflammatory bowel disease Source: Eur Respir J 2003; 22: Suppl. 45, 480s Year: 2003
Infliximab treatment in patients with interstitial lung disease and rheumatoid arthritis Source: Eur Respir J 2002; 20: Suppl. 38, 587s Year: 2002
How to treat bronchial granuloma in chronic granulomatous disease? Source: Eur Respir J 2004; 24: Suppl. 48, 49s Year: 2004
Treatment of ulcerative endobronchial tuberculosis and bronchial stenosis with aerosolized streptomycin and steroids Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001
Eosinophilic refractory inflammation in OCS-dependent severe asthma Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
Pathology of pulmonary involvement in inflammatory bowel disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=199 Year: 2007
Differential treatment response to mepolizumab in severe eosinophilic asthma with nasal polyps Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis Source: Eur Respir J 2004; 24 : 708 Year: 2004
Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma Source: International Congress 2017 – Asthma management Year: 2017